Carna Biosciences, Inc.
Status: Publicly traded
Direct answer
Carna Biosciences, Inc. is publicly traded on JPX under the ticker 4572.T.
Carna Biosciences, Inc., established in Kobe, Japan in 2003, operates as a clinical-stage biopharmaceutical company. Its core focus is on discovering and developing novel drug treatments for significant unmet medical needs, particularly within the Japanese market. In addition to its drug discovery efforts, Carna Biosciences offers an array of specialized research tools. These comprise diverse kinase proteins, their...
Can you invest in Carna Biosciences, Inc.?
Yes. Carna Biosciences, Inc. is publicly traded on JPX under the ticker 4572.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Carna Biosciences, Inc.
Detailed equity research is provided by MarketSnap.